Is routine gastroscopy/colonoscopy reasonable in patients with suspected ovarian cancer: A retrospective study

Guochen Liu, Junping Yan, Shanshan Long, Zhimin Liu, Haifeng Gu, Hua Tu, Jundong LiResearch Square 2021 · DOI

TL;DR

Routine gastrointestinal (GI) endoscopy for all patients with suspected ovarian cancer may be unnecessary and inefficient. This retrospective study suggests that a "risk-adapted" approach—using imaging and tumor markers to trigger endoscopy only when needed—could spare over 60% of patients from invasive procedures without compromising diagnostic accuracy or surgical planning.

What Problem Does This Paper Address?

When a patient presents with a pelvic mass suspected to be ovarian cancer, clinicians face a diagnostic dilemma: is the cancer primary to the ovary, or is it a metastasis from the digestive tract (often called a Krukenberg tumor)? Current guidelines, such as those from the NCCN, often suggest routine gastroscopy and colonoscopy to rule out a GI primary.

However, these endoscopic procedures are invasive, costly, and can delay the start of treatment. Furthermore, surgeons often use endoscopy to predict whether a patient will need a bowel resection during surgery. The authors of this study questioned whether the "routine" nature of these tests is truly justified or if standard imaging and blood work provide enough information to make these calls.

Methods

The researchers conducted a retrospective study at the Sun Yat-sen University Cancer Center, analyzing data from 389 women who underwent preoperative gastroscopy/colonoscopy for suspected ovarian cancer between 2016 and 2019.

They compared the diagnostic performance (sensitivity, specificity, and diagnostic efficiency) of:

  1. GI Endoscopy (Gastroscopy and Colonoscopy)
  2. Preoperative Imaging (Ultrasound, CT, MRI, and PET-CT)
  3. Tumor Markers (CA125, CEA, HE4, and CA199)

The "gold standard" for comparison was the final pathological diagnosis from biopsy or surgery. They also specifically looked at how well colonoscopy predicted the need for intestinal resection compared to imaging.

Datasets

The study utilized a clinical dataset of 1,851 patients initially screened, resulting in a final cohort of 389 eligible patients.

  • Primary ovarian tumors: 339 cases.
  • Ovarian metastatic tumors: 40 cases (including 11 gastric cancers and 9 colonic cancers).
  • Other: The cohort also included borderline tumors, benign masses, and rare metastases (e.g., from the appendix or pancreas).

Key Insights and Ideas

  • The "Red Flag" Rule: In almost every case where a patient actually had GI-origin metastasis, there were already "indicative" signs in their imaging or tumor markers. Only one patient with gastric cancer had a "false negative" on initial non-invasive screening.
  • Endoscopy isn't a Crystal Ball for Surgery: One major justification for preoperative colonoscopy is to prepare for bowel resection. However, the study found that imaging was actually more specific (87.8% vs. 74.3%) than colonoscopy at predicting the need for an intestinal incision.
  • Low Yield: Only 5.7% of the suspected ovarian cancer cases were actually metastases from the GI tract. This low incidence suggests that performing endoscopy on 100% of patients is an inefficient use of resources.
  • The Power of Ratios: The researchers highlighted the CA125/CEA ratio as a particularly useful tool. A lower ratio often points toward a GI primary rather than an ovarian primary.

Key Results

  • Diagnostic Parity: There was no statistically significant difference between endoscopy and imaging for detecting metastases. Endoscopy showed 55.0% sensitivity and 99.4% specificity, while imaging showed 45.2% sensitivity and 99.7% specificity.
  • Surgical Prediction: For predicting bowel resection, colonoscopy and imaging had similar sensitivities (~61% vs ~44%, P=0.804), but imaging was significantly better at avoiding "false alarms" (higher specificity).
  • Potential Savings: The authors estimate that 62.2% of patients could have safely avoided GI endoscopy if the procedures were only performed based on suspicious imaging or abnormal tumor markers.

Limitations and Future Work

The study is retrospective, meaning it relies on existing records which can introduce selection bias. The sample size for certain subgroups (like benign tumors) was relatively small, which might limit the statistical power of some comparisons. Additionally, the study did not include physical examination findings as a formal indicator, which is a standard part of clinical practice.

The authors suggest that future prospective studies are needed to establish a formal "risk-adapted" algorithm. Such an algorithm would define exactly which thresholds of tumor markers or which specific imaging findings should trigger a gastroscopy or colonoscopy, moving away from a "one-size-fits-all" preoperative checklist.

Summary updated

Abstract

<title>Abstract</title> <bold>Objective </bold>To evaluate the value of routine preoperative gastroscopy/colonoscopy in patients with suspected ovarian cancer for differential diagnosis and judgment of bowel resection.<bold>Methods </bold>All women diagnosed with suspected ovarian cancer who underwent gastroscopy/colonoscopy before surgery in our center were retrospectively identified. Gastroscopy/colonoscopy results and clinical pathology, imaging, and surgical findings were analyzed.<bold>Results </bold>389 patients were included. Among them, 40 were ovarian metastasis. Compared with imaging, gastrointestinal endoscopy showed no statistical advantage in the specificity and sensitivity (99.4% vs. 99.7%, <italic>P</italic> = 1.0; 55.0% vs. 45.2%, <italic>P</italic> = 0.057; respectively). All patients with gastric/colonic cancer metastasize except for one had indicative imaging or tumor marker abnormalities. Three patients with colonic cancer metastases underwent optimal surgery and alive with no recurrence, the other 19 patients experienced palliative chemotherapy. There is no significant difference in the sensitivity of colonoscopy and imaging in predicting intestinal incision (61.5% vs. 43.8%, <italic>P</italic> = 0.804), whereas, the latter had higher specificity (87.8% vs. 74.3%, <italic>P</italic> = 0.001).<bold>Conclusions </bold>For patients with suspected ovarian cancer, the incidence of gastrointestinal metastases is low, routine gastroscopy/colonoscopy before treatment is less efficient. Gastroscopy/colonoscopy has limited power to predict the need for gastrointestinal resection before ovarian cancer surgery.
BibTeX
@inproceedings{liu2021is,
  author = {Guochen Liu and Junping Yan and Shanshan Long and Zhimin Liu and Haifeng Gu and Hua Tu and Jundong Li},
  title = {{Is routine gastroscopy/colonoscopy reasonable in patients with suspected ovarian cancer: A retrospective study}},
  booktitle = {Research Square},
  year = {2021},
  doi = {10.21203/rs.3.rs-329104/v1},
}
Figure